Clinical Trials Directory

Trials / Completed

CompletedNCT04436835

Psychotherapy (Accelerated Resolution Therapy) for Cancer Related Trauma and Distress

Accelerated Resolution Therapy for Cancer Related Trauma and Distress: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies whether a form of psychotherapy called accelerated resolution therapy can help with cancer distress and psychological trauma. Accelerated resolution therapy is an evidence-based therapy for the treatment of depressive symptoms, trauma, and stress-related disorders. This study may provide evidence to support integration of accelerated resolution therapy into psychological treatment of cancer patients, which may decrease cancer related trauma and distress.

Detailed description

PRIMARY OBJECTIVES: I. Calculate changes, and estimate mean changes, in primary outcomes of psychological trauma and cancer distress over a six week time period while receiving weekly accelerated resolution therapy (ART). II. Calculate changes, and estimate mean changes, in secondary outcomes of anxiety and depression over a six week period while receiving weekly ART. III. Will use a qualitative, descriptive design to explore contextual elements of the cancer experience that are consistently distressing and/or psychologically traumatic to more fully inform a future RCT testing in ART in cancer distress and psychological trauma. IV. Calculate changes, and estimate mean changes, in secondary outcomes of resilience and symptom distress over a six week period while receiving weekly ART. OUTLINE: Patients undergo ART over 60-90 minutes once a week for up to 5 sessions. After completion of study intervention, patients are followed up at 1 week and again at 1 month.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychotherapyUndergo ART
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2019-11-27
Primary completion
2021-08-19
Completion
2021-08-19
First posted
2020-06-18
Last updated
2024-12-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04436835. Inclusion in this directory is not an endorsement.